Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04927013 · ClinicalTrials.gov registry record · NA

Connecting Families to Overcome Ovarian Cancer

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
2,331
Enrollment target

NCT04927013 is a NA study that has completed, run by Emory University. The registered enrollment target is 2,331 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04927013, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
2,331 participants
Enrollment target

Study Summary

This study tests a multi-component, low cost, message-based communication outreach intervention to engage ovarian cancer survivors and their at-risk relatives in considering cancer genetic services. The intervention includes foot-in-the-door techniques, tailored/targeted print, website support, and short messages to expand reach of prevention messages.

Interventions

  • BEHAVIORAL Message-based Outreach Intervention for Survivors
  • BEHAVIORAL Standard Outreach for Survivors
  • BEHAVIORAL Message-based Outreach Intervention for Close Relatives
  • BEHAVIORAL Standard Outreach for Close Relatives

Trial Details

FieldValue
Enrollment Target 2,331 participants
Start Date 2021-07-24
Est. Completion 2023-02-21
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT04927013

The ClinicalTrials.gov registry entry for NCT04927013 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,331 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Message-based Outreach Intervention for Survivors is the first listed.

NCT04927013 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04927013 about?

NCT04927013 is a clinical study titled "Connecting Families to Overcome Ovarian Cancer". This study tests a multi-component, low cost, message-based communication outreach intervention to engage ovarian cancer survivors and their at-risk relatives in considering cancer genetic services. The intervention includes foot-in-the-door techniques, tailored/targeted print, website support, and ...

What is the current status of trial NCT04927013?

This trial is currently completed. It is a NA study. The enrollment target is 2,331 participants. The study started on 2021-07-24. Estimated completion is 2023-02-21.

What interventions are being tested in trial NCT04927013?

The interventions under investigation include: Message-based Outreach Intervention for Survivors (BEHAVIORAL), Standard Outreach for Survivors (BEHAVIORAL), Message-based Outreach Intervention for Close Relatives (BEHAVIORAL), Standard Outreach for Close Relatives (BEHAVIORAL).

Who is sponsoring clinical trial NCT04927013?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.